阿森迪斯制药 ASND
$256.82 +$3.37 (+1.33%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $256.82 0.00%
开盘$253.45
昨收$253.45
当日区间$251.02 – $258.46
成交量883.8K
市值$16.90B
市盈率（TTM）20.5
股息率–
财报
财报日平均波动±4.4%近16次财报
收涨次数9 / 1656% 的概率
最佳反应+13.0%
最差反应-11.3%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 13 Aug 2026 | Pre Market | ±6.2% | -3.61% | 符合区间 |
| 2026/Q1 | 7 May 2026 | Pre Market | ±7.6% | +4.34% | 符合区间 |
| 2025/Q4 | 11 Feb 2026 | After Market | ±6.2% | -1.53% | 符合区间 |
| 2025/Q3 | 12 Nov 2025 | After Market | ±8.2% | +3.63% | 符合区间 |
| 2025/Q2 | 7 Aug 2025 | After Market | ±12.0% | +0.60% | 符合区间 |
| 2025/Q1 | 1 May 2025 | After Market | ±10.4% | +2.74% | 符合区间 |
| 2024/Q4 | 12 Feb 2025 | After Market | ±7.9% | +12.96% | 超出定价预期 |
| 2024/Q3 | 14 Nov 2024 | After Market | ±21.0% | +1.79% | 符合区间 |
| 2024/Q2 | 3 Sep 2024 | After Market | ±9.9% | -11.27% | 超出定价预期 |
| 2024/Q1 | 2 May 2024 | After Market | ±21.8% | -2.76% | 符合区间 |
| 2023/Q4 | 7 Feb 2024 | After Market | ±10.4% | -0.03% | 符合区间 |
| 2023/Q3 | 7 Nov 2023 | After Market | ±9.5% | -1.47% | 符合区间 |
| 2023/Q2 | 5 Sep 2023 | After Market | ±15.2% | +4.24% | 符合区间 |
| 2023/Q1 | 27 Apr 2023 | After Market | ±19.3% | -9.12% | 符合区间 |
| 2022/Q4 | 16 Feb 2023 | After Market | – | +4.75% | – |
| 2022/Q3 | 2 Nov 2022 | After Market | ±17.9% | +5.13% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026 · 报告货币为EUR
营收€339.29M+114.7% YoY
营业利润€220.47M+516.4% YoY
净利润€206.97M+632.7% YoY
摊薄每股收益€2.83+445.1% YoY
自由现金流€270.73M+2,286.5% YoY
经营现金流€281.68M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率91.3%
营业利润率25.1%
净利率70.8%
净资产收益率118.8%
资产收益率44.0%
投入资本回报率62.3%
流动比率2.99
负债/资产比率37.2%
现金及投资€812.26M
总负债€450.07M
净现金（净负债）€362.19M
自由现金流/营收32.0%
暂无评论——快来第一个聊聊 ASND。
登录后参与讨论。